Mikhail Ivanovich Papisov, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Iodine Radioisotopes | 4 | 2012 | 1029 | 0.620 |
Why?
|
| Acids, Heterocyclic | 1 | 2012 | 1 | 0.420 |
Why?
|
| Sulfuric Acid Esters | 1 | 2012 | 33 | 0.410 |
Why?
|
| Drug Delivery Systems | 4 | 2013 | 2212 | 0.390 |
Why?
|
| Polymers | 3 | 2005 | 1624 | 0.320 |
Why?
|
| Central Nervous System Diseases | 1 | 2013 | 518 | 0.310 |
Why?
|
| Biocompatible Materials | 3 | 2005 | 1690 | 0.300 |
Why?
|
| Radiopharmaceuticals | 3 | 2019 | 2702 | 0.290 |
Why?
|
| Pentetic Acid | 4 | 2005 | 209 | 0.280 |
Why?
|
| Lymph Nodes | 5 | 2005 | 3468 | 0.250 |
Why?
|
| Contrast Media | 8 | 2019 | 5329 | 0.240 |
Why?
|
| Phagocytes | 1 | 2005 | 292 | 0.210 |
Why?
|
| Drug Carriers | 4 | 1996 | 702 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2015 | 8108 | 0.200 |
Why?
|
| Positron-Emission Tomography | 5 | 2019 | 6550 | 0.200 |
Why?
|
| Glycine | 1 | 2004 | 670 | 0.180 |
Why?
|
| Camptothecin | 1 | 2004 | 599 | 0.180 |
Why?
|
| Rats | 16 | 2019 | 23713 | 0.170 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2019 | 30 | 0.170 |
Why?
|
| Tissue Distribution | 7 | 2019 | 2275 | 0.160 |
Why?
|
| Macromolecular Substances | 3 | 2013 | 1430 | 0.160 |
Why?
|
| Nanotechnology | 1 | 2005 | 702 | 0.160 |
Why?
|
| Magnetics | 6 | 1988 | 586 | 0.150 |
Why?
|
| Isotope Labeling | 2 | 2019 | 390 | 0.150 |
Why?
|
| Dimethylformamide | 2 | 2015 | 20 | 0.140 |
Why?
|
| Drug Design | 2 | 2019 | 1045 | 0.140 |
Why?
|
| Axonal Transport | 2 | 2013 | 178 | 0.130 |
Why?
|
| Hydrocarbons, Iodinated | 1 | 2015 | 8 | 0.130 |
Why?
|
| Isradipine | 1 | 2015 | 12 | 0.130 |
Why?
|
| Organometallic Compounds | 2 | 1996 | 648 | 0.120 |
Why?
|
| Injections, Spinal | 2 | 2013 | 317 | 0.120 |
Why?
|
| Kinetics | 5 | 2005 | 6287 | 0.120 |
Why?
|
| Cations | 2 | 2005 | 239 | 0.120 |
Why?
|
| Hydrolysis | 2 | 2005 | 645 | 0.110 |
Why?
|
| Lymphatic Diseases | 1 | 1996 | 318 | 0.110 |
Why?
|
| Rejuvenation | 1 | 2015 | 109 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 903 | 0.110 |
Why?
|
| Myosins | 1 | 1995 | 406 | 0.110 |
Why?
|
| Triazoles | 1 | 2019 | 903 | 0.110 |
Why?
|
| Carbohydrates | 2 | 2005 | 387 | 0.110 |
Why?
|
| Models, Chemical | 2 | 2005 | 607 | 0.110 |
Why?
|
| Cosmetic Techniques | 1 | 2015 | 149 | 0.110 |
Why?
|
| Glucose | 1 | 2005 | 4341 | 0.100 |
Why?
|
| Biological Transport, Active | 1 | 2013 | 323 | 0.100 |
Why?
|
| Central Nervous System Agents | 1 | 2013 | 71 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 2535 | 0.100 |
Why?
|
| Cross-Linking Reagents | 2 | 2005 | 689 | 0.100 |
Why?
|
| Iduronate Sulfatase | 1 | 2012 | 10 | 0.100 |
Why?
|
| Epidermis | 1 | 2015 | 539 | 0.100 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2012 | 26 | 0.100 |
Why?
|
| Calcium Channel Blockers | 1 | 2015 | 688 | 0.100 |
Why?
|
| Ferric Compounds | 3 | 1993 | 376 | 0.100 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2012 | 80 | 0.090 |
Why?
|
| Solvents | 1 | 2012 | 298 | 0.090 |
Why?
|
| Meninges | 1 | 2013 | 197 | 0.090 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 1029 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 2478 | 0.090 |
Why?
|
| Rabbits | 6 | 2005 | 4751 | 0.090 |
Why?
|
| Proteins | 1 | 2005 | 6001 | 0.090 |
Why?
|
| Animals | 25 | 2019 | 168965 | 0.090 |
Why?
|
| Haplorhini | 1 | 2011 | 520 | 0.090 |
Why?
|
| Rats, Inbred F344 | 2 | 2005 | 820 | 0.080 |
Why?
|
| Dextrans | 4 | 2005 | 574 | 0.080 |
Why?
|
| Oxides | 3 | 1994 | 402 | 0.080 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 635 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 3726 | 0.080 |
Why?
|
| Polysaccharides | 2 | 2005 | 1020 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2005 | 3684 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 8 | 1996 | 36582 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 1733 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 6360 | 0.070 |
Why?
|
| Genes, Regulator | 1 | 2007 | 373 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 2221 | 0.070 |
Why?
|
| Models, Animal | 1 | 2013 | 2121 | 0.070 |
Why?
|
| Fluorine Radioisotopes | 2 | 2019 | 405 | 0.070 |
Why?
|
| Autoantibodies | 1 | 1995 | 2114 | 0.070 |
Why?
|
| Ketoses | 1 | 2005 | 3 | 0.060 |
Why?
|
| Drug Stability | 2 | 2004 | 289 | 0.060 |
Why?
|
| Gels | 2 | 2005 | 421 | 0.060 |
Why?
|
| Ethylenediamines | 1 | 2005 | 57 | 0.060 |
Why?
|
| Tissue Engineering | 2 | 2005 | 1861 | 0.060 |
Why?
|
| Models, Molecular | 2 | 2005 | 5388 | 0.060 |
Why?
|
| Polyethylene Glycols | 2 | 2005 | 1188 | 0.060 |
Why?
|
| Polylysine | 1 | 2005 | 130 | 0.060 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 152 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2005 | 13650 | 0.060 |
Why?
|
| Biopolymers | 1 | 2005 | 182 | 0.060 |
Why?
|
| Half-Life | 2 | 2015 | 648 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2012 | 1345 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 766 | 0.060 |
Why?
|
| Oxygen | 2 | 2005 | 4252 | 0.050 |
Why?
|
| Particle Size | 2 | 2005 | 1633 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 1996 | 1377 | 0.050 |
Why?
|
| Biotechnology | 1 | 2005 | 282 | 0.050 |
Why?
|
| Oligosaccharides | 1 | 2005 | 406 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2007 | 623 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2005 | 250 | 0.050 |
Why?
|
| Brain | 4 | 2019 | 27163 | 0.050 |
Why?
|
| Iron | 3 | 1994 | 1811 | 0.050 |
Why?
|
| Carbon | 1 | 2005 | 672 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1531 | 0.050 |
Why?
|
| Indium Radioisotopes | 3 | 1996 | 114 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2004 | 965 | 0.040 |
Why?
|
| Autoradiography | 2 | 2019 | 725 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2004 | 1882 | 0.040 |
Why?
|
| Protons | 1 | 2005 | 1101 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 2 | 1985 | 1085 | 0.040 |
Why?
|
| Spiro Compounds | 1 | 2019 | 69 | 0.040 |
Why?
|
| Liposomes | 2 | 1994 | 787 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10455 | 0.040 |
Why?
|
| Time Factors | 3 | 2005 | 40154 | 0.040 |
Why?
|
| Temperature | 1 | 2005 | 2232 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 1996 | 10254 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2004 | 3618 | 0.040 |
Why?
|
| Mice | 5 | 2012 | 81912 | 0.040 |
Why?
|
| Enzymes, Immobilized | 3 | 1988 | 53 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2004 | 3608 | 0.030 |
Why?
|
| Gadolinium DTPA | 2 | 1996 | 823 | 0.030 |
Why?
|
| Radioimmunodetection | 1 | 1995 | 45 | 0.030 |
Why?
|
| Body Weight | 1 | 2005 | 4627 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2015 | 204 | 0.030 |
Why?
|
| Cell Survival | 1 | 2004 | 5750 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1996 | 1309 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 1995 | 11513 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 2015 | 544 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1996 | 1062 | 0.030 |
Why?
|
| Siloxanes | 1 | 1993 | 27 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5311 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1996 | 2168 | 0.030 |
Why?
|
| Asialoglycoproteins | 1 | 1993 | 19 | 0.030 |
Why?
|
| Lymphatic Metastasis | 3 | 1996 | 2900 | 0.030 |
Why?
|
| Binding Sites | 2 | 2019 | 6014 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 721 | 0.030 |
Why?
|
| Ferrosoferric Oxide | 3 | 1994 | 348 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1996 | 496 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4968 | 0.030 |
Why?
|
| Silicones | 1 | 1993 | 228 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 1993 | 229 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 1331 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2015 | 622 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 1992 | 141 | 0.020 |
Why?
|
| Necrosis | 1 | 1995 | 1614 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 7063 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 908 | 0.020 |
Why?
|
| Dogs | 2 | 2012 | 3834 | 0.020 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1988 | 49 | 0.020 |
Why?
|
| Troponin C | 1 | 2007 | 48 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2012 | 539 | 0.020 |
Why?
|
| Streptokinase | 1 | 1988 | 186 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 17097 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1996 | 4026 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 147 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 2412 | 0.020 |
Why?
|
| Mathematics | 1 | 1988 | 696 | 0.020 |
Why?
|
| Male | 10 | 2015 | 364203 | 0.020 |
Why?
|
| Fibrinolytic Agents | 2 | 1988 | 2079 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6226 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1275 | 0.020 |
Why?
|
| Lysosomes | 1 | 2012 | 937 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 18063 | 0.020 |
Why?
|
| Humans | 7 | 2013 | 767040 | 0.010 |
Why?
|
| Colloids | 1 | 1984 | 125 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2012 | 1811 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1995 | 3837 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2005 | 23621 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6507 | 0.010 |
Why?
|
| Myocardium | 1 | 1995 | 4765 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3587 | 0.010 |
Why?
|
| Microspheres | 1 | 1984 | 774 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4572 | 0.010 |
Why?
|
| Liver | 2 | 1993 | 7578 | 0.010 |
Why?
|
| Radionuclide Imaging | 2 | 1994 | 1987 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 4925 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 1722 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 8940 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11063 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 9245 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14476 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1996 | 18330 | 0.010 |
Why?
|
| Female | 3 | 2015 | 396660 | 0.010 |
Why?
|
| Chymotrypsin | 2 | 1986 | 136 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1994 | 47 | 0.010 |
Why?
|
| Femoral Nerve | 1 | 1994 | 42 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1994 | 540 | 0.010 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 1993 | 36 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1995 | 685 | 0.010 |
Why?
|
| Neurons | 1 | 2012 | 9517 | 0.010 |
Why?
|
| Surface Properties | 1 | 1994 | 1154 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 1994 | 627 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1994 | 1150 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11923 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1993 | 1418 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 1928 | 0.000 |
Why?
|
| Cyanogen Bromide | 1 | 1985 | 75 | 0.000 |
Why?
|
| Antibody Affinity | 1 | 1986 | 251 | 0.000 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1986 | 324 | 0.000 |
Why?
|
| Methods | 1 | 1985 | 1065 | 0.000 |
Why?
|
| Thermodynamics | 1 | 1985 | 581 | 0.000 |
Why?
|
| Fibrin | 1 | 1986 | 514 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1986 | 892 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1985 | 676 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1994 | 6260 | 0.000 |
Why?
|
| Thrombosis | 1 | 1986 | 2954 | 0.000 |
Why?
|